ArticleFrontiers in psychiatry2025
Intimate partner and family violence and mental health during the SARS-CoV-2 pandemic: a multi-country survey.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: During COVID-19, concerns were raised about a 'shadow pandemic' of violence against women and girls. However, UN guidance discouraged direct enquiry about intimate partner and family violence (IPFV), instead advocating proxy questions on subjects like relationship difficulties and perceived safety. We investigated the relationship between partner difficulties and family difficulties and common mental disorder (CMDs) during COVID-19 in low-, middle-, and high-income countries. Methods: We carried out and analysed an online survey, measuring partner difficulties and family difficulties (as proxy items for IPFV), CMDs, and socioeconomic risk factors. Results: There were 409 respondents in 19 countries. The prevalence of CMDs was 32.27%. After all adjustments, the risk ratio (RR) for the association of partner difficulties with CMD was 1.30 (95% CI: 1.06, 1.60). The adjusted RR of family difficulties with CMD was 1.18 (95% CI: 0.97, 1.44). Both partner and family difficulties were significantly associated with CMD in women [partner difficulties RR = 1.31 (95% CI: 1.05, 1.65); family difficulties RR = 1.37 (95% CI: 1.09, 1.72)]. Conclusion: Collecting proxy data on IPFV is feasible and was related to CMDs during COVID-19 in a range of settings. Like partner violence, family violence may also be related to increased CMDs, especially in women. Policy responses for post-pandemic recovery and preparation for future emergencies should consider the health impacts of family violence as well as partner violence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.